GLI1 and hepatocellular carcinoma: Significantly, LIN28B-AS1 siRNA or KO downregulated IGF2BP1-dependent mRNAs (IGF2, Gli1, and Myc), leading to potent inhibition on HCC cell growth, proliferation, migration, and invasion.